Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 10 studies | 27% ± 9% | |
ciliated cell | 4 studies | 21% ± 3% | |
neuron | 3 studies | 34% ± 10% | |
glutamatergic neuron | 3 studies | 35% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 13479.34 | 2641 / 2642 | 100% | 206.60 | 703 / 705 |
adrenal gland | 90% | 2346.54 | 231 / 258 | 94% | 108.07 | 216 / 230 |
pancreas | 93% | 2700.41 | 306 / 328 | 61% | 13.43 | 109 / 178 |
prostate | 46% | 824.64 | 112 / 245 | 97% | 28.80 | 488 / 502 |
ovary | 21% | 335.41 | 38 / 180 | 97% | 56.33 | 415 / 430 |
kidney | 30% | 542.79 | 27 / 89 | 68% | 12.67 | 611 / 901 |
uterus | 46% | 830.75 | 78 / 170 | 45% | 11.57 | 208 / 459 |
eye | 0% | 0 | 0 / 0 | 69% | 9.74 | 55 / 80 |
breast | 5% | 80.62 | 22 / 459 | 61% | 12.25 | 679 / 1118 |
thymus | 10% | 163.68 | 63 / 653 | 52% | 6.86 | 313 / 605 |
skin | 0% | 4.70 | 5 / 1809 | 55% | 10.59 | 260 / 472 |
lung | 2% | 28.31 | 9 / 578 | 45% | 7.61 | 521 / 1155 |
stomach | 14% | 268.24 | 52 / 359 | 26% | 5.07 | 75 / 286 |
esophagus | 9% | 159.44 | 126 / 1445 | 30% | 4.69 | 54 / 183 |
intestine | 8% | 136.90 | 81 / 966 | 21% | 3.48 | 112 / 527 |
bladder | 5% | 65.67 | 1 / 21 | 19% | 3.73 | 98 / 504 |
liver | 0% | 0 | 0 / 226 | 20% | 2.83 | 82 / 406 |
tonsil | 0% | 0 | 0 / 0 | 16% | 8.40 | 7 / 45 |
adipose | 3% | 63.35 | 34 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 35.81 | 22 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 4.94 | 3 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007254 | Biological process | JNK cascade |
GO_0046328 | Biological process | regulation of JNK cascade |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_2000564 | Biological process | regulation of CD8-positive, alpha-beta T cell proliferation |
GO_0043508 | Biological process | negative regulation of JUN kinase activity |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_2001243 | Biological process | negative regulation of intrinsic apoptotic signaling pathway |
GO_0044302 | Cellular component | dentate gyrus mossy fiber |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0008432 | Molecular function | JUN kinase binding |
GO_0005078 | Molecular function | MAP-kinase scaffold activity |
GO_0005515 | Molecular function | protein binding |
GO_0019894 | Molecular function | kinesin binding |
Gene name | MAPK8IP1 |
Protein name | Mitogen-activated protein kinase 8 interacting protein 1 C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1) |
Synonyms | IB1 PRKM8IP JIP1 |
Description | FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Required for JNK activation in response to excitotoxic stress. Cytoplasmic MAPK8IP1 causes inhibition of JNK-regulated activity by retaining JNK in the cytoplasm and inhibiting JNK phosphorylation of c-Jun. May also participate in ApoER2-specific reelin signaling. Directly, or indirectly, regulates GLUT2 gene expression and beta-cell function. Appears to have a role in cell signaling in mature and developing nerve terminals. May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins. Functions as an anti-apoptotic protein and whose level seems to influence the beta-cell death or survival response. Acts as a scaffold protein that coordinates with SH3RF1 in organizing different components of the JNK pathway, including RAC1 or RAC2, MAP3K11/MLK3 or MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and/or MAPK9/JNK2 into a functional multiprotein complex to ensure the effective activation of the JNK signaling pathway. Regulates the activation of MAPK8/JNK1 and differentiation of CD8(+) T-cells. . |
Accessions | Q9UQF2 ENST00000395629.2 Q6NUQ9 ENST00000241014.6 E9PBB9 |